138 related articles for article (PubMed ID: 16613989)
1. Down-regulation of the tumor suppressor gene retinoic acid receptor beta2 through the phosphoinositide 3-kinase/Akt signaling pathway.
Lefebvre B; Brand C; Flajollet S; Lefebvre P
Mol Endocrinol; 2006 Sep; 20(9):2109-21. PubMed ID: 16613989
[TBL] [Abstract][Full Text] [Related]
2. Combination of retinoid and histone deacetylase inhibitor produced an anti-tumor effect in cutaneous T-cell lymphoma by restoring tumor suppressor gene, retinoic acid receptorβ2, via histone acetylation.
Kato Y; Egusa C; Maeda T; Tsuboi R
J Dermatol Sci; 2016 Jan; 81(1):17-25. PubMed ID: 26596218
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid receptor (GR)-associated SMRT binding to C/EBPbeta TAD and Nrf2 Neh4/5: role of SMRT recruited to GR in GSTA2 gene repression.
Ki SH; Cho IJ; Choi DW; Kim SG
Mol Cell Biol; 2005 May; 25(10):4150-65. PubMed ID: 15870285
[TBL] [Abstract][Full Text] [Related]
4. The nuclear corepressors recognize distinct nuclear receptor complexes.
Cohen RN; Putney A; Wondisford FE; Hollenberg AN
Mol Endocrinol; 2000 Jun; 14(6):900-14. PubMed ID: 10847591
[TBL] [Abstract][Full Text] [Related]
5. In vivo imaging of retinoic acid receptor beta2 transcriptional activation by the histone deacetylase inhibitor MS-275 in retinoid-resistant prostate cancer cells.
Qian DZ; Ren M; Wei Y; Wang X; van de Geijn F; Rasmussen C; Nakanishi O; Sacchi N; Pili R
Prostate; 2005 Jun; 64(1):20-8. PubMed ID: 15651062
[TBL] [Abstract][Full Text] [Related]
6. Signaling by tyrosine kinases negatively regulates the interaction between transcription factors and SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) corepressor.
Hong SH; Wong CW; Privalsky ML
Mol Endocrinol; 1998 Aug; 12(8):1161-71. PubMed ID: 9717842
[TBL] [Abstract][Full Text] [Related]
7. A corepressor and chicken ovalbumin upstream promoter transcriptional factor proteins modulate peroxisome proliferator-activated receptor-gamma2/retinoid X receptor alpha-activated transcription from the murine lipoprotein lipase promoter.
Robinson CE; Wu X; Nawaz Z; Onãte SA; Gimble JM
Endocrinology; 1999 Apr; 140(4):1586-93. PubMed ID: 10098492
[TBL] [Abstract][Full Text] [Related]
8. Retinoid receptors in health and disease: co-regulators and the chromatin connection.
Minucci S; Pelicci PG
Semin Cell Dev Biol; 1999 Apr; 10(2):215-25. PubMed ID: 10441075
[TBL] [Abstract][Full Text] [Related]
9. The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains.
Cohen RN; Brzostek S; Kim B; Chorev M; Wondisford FE; Hollenberg AN
Mol Endocrinol; 2001 Jul; 15(7):1049-61. PubMed ID: 11435607
[TBL] [Abstract][Full Text] [Related]
10. Retinyl methyl ether down-regulates activator protein 1 transcriptional activation in breast cancer cells.
Agadir A; Shealy YF; Hill DL; Zhang X
Cancer Res; 1997 Aug; 57(16):3444-50. PubMed ID: 9270011
[TBL] [Abstract][Full Text] [Related]
11. The promoter context is a decisive factor in establishing selective responsiveness to nuclear class II receptors.
Sanguedolce MV; Leblanc BP; Betz JL; Stunnenberg HG
EMBO J; 1997 May; 16(10):2861-73. PubMed ID: 9184230
[TBL] [Abstract][Full Text] [Related]
12. Akt phosphorylates and suppresses the transactivation of retinoic acid receptor alpha.
Srinivas H; Xia D; Moore NL; Uray IP; Kim H; Ma L; Weigel NL; Brown PH; Kurie JM
Biochem J; 2006 May; 395(3):653-62. PubMed ID: 16417524
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of Notch-dependent transcription by Akt in vitro.
Song J; Park S; Kim M; Shin I
FEBS Lett; 2008 May; 582(12):1693-9. PubMed ID: 18440314
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic modulation of retinoic acid receptor beta2 by the histone deacetylase inhibitor MS-275 in human renal cell carcinoma.
Wang XF; Qian DZ; Ren M; Kato Y; Wei Y; Zhang L; Fansler Z; Clark D; Nakanishi O; Pili R
Clin Cancer Res; 2005 May; 11(9):3535-42. PubMed ID: 15867257
[TBL] [Abstract][Full Text] [Related]
15. Suppression of nephrin expression by TNF-alpha via interfering with the cAMP-retinoic acid receptor pathway.
Saito Y; Okamura M; Nakajima S; Hayakawa K; Huang T; Yao J; Kitamura M
Am J Physiol Renal Physiol; 2010 Jun; 298(6):F1436-44. PubMed ID: 20237236
[TBL] [Abstract][Full Text] [Related]
16. The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor.
Yoon HG; Wong J
Mol Endocrinol; 2006 May; 20(5):1048-60. PubMed ID: 16373395
[TBL] [Abstract][Full Text] [Related]
17. Regulation of retinoid-induced differentiation in embryonal carcinoma PCC4.aza1R cells: effects of retinoid-receptor selective ligands.
Mills KJ; Vollberg TM; Nervi C; Grippo JF; Dawson MI; Jetten AM
Cell Growth Differ; 1996 Mar; 7(3):327-37. PubMed ID: 8838863
[TBL] [Abstract][Full Text] [Related]
18. Endogenous reactivation of the RARbeta2 tumor suppressor gene epigenetically silenced in breast cancer.
Sirchia SM; Ren M; Pili R; Sironi E; Somenzi G; Ghidoni R; Toma S; Nicolò G; Sacchi N
Cancer Res; 2002 May; 62(9):2455-61. PubMed ID: 11980632
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of nuclear receptor corepressor (N-CoR) expression levels on retinoic acid receptor-mediated repression support the existence of dynamically regulated corepressor complexes.
Söderström M; Vo A; Heinzel T; Lavinsky RM; Yang WM; Seto E; Peterson DA; Rosenfeld MG; Glass CK
Mol Endocrinol; 1997 Jun; 11(6):682-92. PubMed ID: 9171232
[TBL] [Abstract][Full Text] [Related]
20. Dynamic inhibition of nuclear receptor activation by corepressor binding.
Sohn YC; Kim SW; Lee S; Kong YY; Na DS; Lee SK; Lee JW
Mol Endocrinol; 2003 Mar; 17(3):366-72. PubMed ID: 12554786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
